title: 5-Lipoxygenase as a putative mechanism of NSAID-related psychiatric adverse events.
authors.forename: Radmila
authors.initials: R
authors.lastname: Manev
authors.forename: Hari
authors.initials: H
authors.lastname: Manev
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001094:Arachidonate 5-Lipoxygenase / Q000235:genetics*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced* / Q000201:enzymology*; D051379:Mice; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D001094:Arachidonate 5-Lipoxygenase
references.citation: Arthritis Rheum. 2004 Dec;50(12):3925-33
references.pmid: 15593193
references.citation: Restor Neurol Neurosci. 2002;20(1-2):15-20
references.pmid: 12237493
references.citation: Drugs. 2004;64(23):2619-27
references.pmid: 15537366
references.citation: N Engl J Med. 2004 Jan 1;350(1):29-37
references.pmid: 14702425
references.citation: Nat Genet. 2004 Mar;36(3):233-9
references.pmid: 14770184
references.citation: Crit Rev Neurobiol. 2004;16(1-2):181-6
references.pmid: 15581413